CDC42 and breast carcinoma: A genomic and transcriptomic analysis by the Molecular Taxonomy of the Breast Cancer International Consortium (METABRIC) demonstrated that less aggressive, ER+ tumours were enriched for altered expression of genes in the CDC42 pathway4.